Article Menu

Export Article

More by Authors Links

Article Data

  • Views 194
  • Dowloads 148

Original Research

Open Access

Parametrial spread is a prognostic factor in endometrial carcinoma

  • R. Sato1,*,
  • T. Jobo1
  • H. Kuramoto2

1Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Japan

2Department of Clinical Cytology, Kitasato University Graduate School of Medical Sciences, Kitasato, Japan

DOI: 10.12892/ejgo200303241 Vol.24,Issue 3-4,July 2003 pp.241-245

Published: 10 July 2003

*Corresponding Author(s): R. Sato E-mail:

PDF (4.22 MB) View Full-text

Abstract

Objective: Parametrial spread of endometrial carcinoma, including the histopathological pattern of the spread and its significance as a prognostic factor, as well as its correlation with other prognostic factors are not well understood.

Methods: We reviewed histopathologically the resected parametria from 269 patients with endometrial carcinoma who underwent radical or modified radical hysterectomy with pelvic lymphadenectomy. The relationship between parametrial spread and other histopathological features, including histological type, tumor grade, depth of myometrial invasion, lymph vascular space invasion (LVSI) of the myometrium, cervical invasion, adnexal metastasis, lymph node metastasis and peritoneal cytology was studied. Clinical outcomes of the patients with parametrial spread were also evaluated.

Results: Parametrial spread was demonstrated in 16 patients (5.9%). Direct invasion of cancer cells to connective tissue, LVSI and lymph-node metastasis in the parametrium were seen in 13, seven and three cases, respectively. Three patients had all three spread patterns. According to the FIGO surgical stage, parametrial spread was found in none of the 164 patients in Stage I, two (6.3%) of 32 in Stage II, 12 (16.9%) of 71 in Stage III, and two (100%) of two in Stage IV. The presence of parametrial involvement was significantly correlated with depth of myometrial invasion, cervical involvement, lymph-node metastasis, adnexal metastasis. LVSI in the myometrium and peritoneal cytology (each, p < 0.01). With a median follow-up of 68.3 months, six (37.5%) of 16 patients with parametrial involvement developed recurrence and died.

Conclusion: Direct parametrial extension or lymphatic involvement within the parametrium can occur in endometrial carcinoma. Patients with parametrial spread have a poor prognosis.

Keywords

Parametrial spread; Endometrial carcinoma; Prognostic factors; Multivariate analysis

Cite and Share

R. Sato,T. Jobo,H. Kuramoto. Parametrial spread is a prognostic factor in endometrial carcinoma. European Journal of Gynaecological Oncology. 2003. 24(3-4);241-245.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200303241

References

[1] International Federation of Gynecology and Obstetrics (FIGO) news. Int. J. Gynecol. Obstet., 1989 - present. 28, 189.

[2] Rutledge F.: "The role of radical hysterectomy in adenocarcinoma of the endometrium". Gynecol. Oncol., 1974, 2, 331.

[3] Kinsella T.J., Bloomer W.D., Lavin P.T., Knapp R.C.: "Stage II endometrial carcinoma: JO-year follow-up of combined radiation and surgical treatment". Gynecol. Oncol., 1980, 10, 290.

[4] Boothby R.A., Carlson J.A., Neiman W., Rubin M.M., Morgan M.A., Schultz D. et al.: "Treatment of stage II endometrial carcinoma". Gynecol. Oncol., 1989, 33, 204.

[5] Mohan D.S., Samuels M.A., Selim M.A., Shalodi AD., Ellis R.J., Samuels J.R. et al.: "Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma". Gynecol. Oncol., 1998, 70, 165.

[6] Girardi F., Petru E., Heydarfadai M., Winter H.R.: "Pelvic lymphadenectomy in the surgical treatment of endometrial cancer". Gynecol. Oncol., 1993, 49, 177.

[7] Larson D.M., Johnson K.K.: "Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrial adenocarcinoma of the endometrium". Gynecol. Oncol., 1993, 51, 345.

[8] Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: "Surgical pathologic spread patterns of endometrial cancer". Cancer, 1987, 60, 2035.

[9] Yura Y., Tauchi K., Koshiyama M., Konishi I., Yura S., Mori T. et al.: "Parametrial involvement in endometrial carcinomas: Its incidence and correlation with other histological parameters". Gynecol. Oncol., 1996, 63, 114.

[10] Tamussino K.F., Reich O., Gucer F., Moser F., Zivkovic F., Lang P.F.J. et al.: "Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy". Int. J. Gynecol. Cancer, 2000,10, 313.

[11] Kottmeier H.L.: "Annual report on the results of treatment in gynecological cancer". FIGO, 1973, 15, 17.

[12] Gusberg S.B.: "The rise and fall of emdometrial cancer". Gynecol. Oncol., 1989, 35, 124.

[13] Homesley H.D., Boronow R.C., Lewis J.L. Jr.: "Stage II endometrial adenocarcinoma: memorial hospital for cancer, 1949-I 965". Obstet. Gynecol., 1977, 49 (5), 604.

[14] Mackillop W.J., Pringle J.F.: "Stage III endometrial carcinoma: a review of 90 cases". Cancer, 1985, 56, 2519.

[15] Schwartz A.E., Brunschwig A.: "Radical panhysterectomy and pelvic node excision for carcinoma of the corpus uteri". Surg. Obstet. Gynecol., 1957, 675.

[16] Takeshima N., Umezawa S., Shimizu Y., Fujimoto I., Yamauchi K., Hasumi K.: "Pelvic lymph node metastasis in endometrial cancer(in Japanese)". Acta Obstet. Gynaecol. Jpn., 1994, 46 (9), 883.

[17] Boente M.P., Grandi Y.A., Yordan E.L., Miller A., Graham J.E., Kirshner C. et al.: "Recurrence pattern and complications in endometrial adenocarcinoma with cervical involvement". Ann. Surg. Oncol., 1995, 2 (2), 138.

[18] Eltabbakh G.H., Moore AD.: "Survival of women with surgical stage II endometrial cancer". Gynecol. Oncol., 1999, 74, 80.

Submission Turnaround Time

Top